I don't think that's entirely how MSBs motivation works.
But with extremely high costs to insurers and hospital institutions, it means the buyers of therapies are looking to cut costs.
And it does mean a higher tolerance on price, sure it does.
Ann: High Economic Burden In Steroid-Refractory aGVHD, page-6
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.025(2.13%) |
Mkt cap ! $1.307B | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.21 | $1.14 | $4.857M | 4.151M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 74671 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 44952 | 21 |
View Market Depth
| Last trade - 11.27am 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.16 |
Change
-0.025 ( 1.47 %) |
||||
| Open | High | Low | Volume | ||
| $1.21 | $1.21 | $1.14 | 582905 | ||
| Last updated 11.49am 27/05/2024 ? | |||||
| MSB (ASX) Chart |